Canada Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Canada Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Summary

GlobalData, the industry analysis specialist, has released its latest report, “Canada Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Canada. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Canada’s pharmaceutical market value in terms of Canadian dollar was worth $21.8B in 2012, which increased at a CAGR of 4.4% to $27B in 2017. However, the pharmaceutical market value in terms of US dollars was $21.8B in 2012, which decreased at a negative CAGR of 0.9% to $20.8B in 2017. The market value is expected to decrease further to $19.5B by 2024.

The pharmaceutical market value is attributed to growing population, changing demographics, increase in disease conditions, changes in physicians’ prescribing practices, the use of newly launched high-cost medicines, uptake of R&D activities to develop new or improved patented therapies, generics, biologics, and biosimilars. However, the stringent pricing policies and currency fluctuations are the barrier to increasing Canadian pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Novartis, Merck, Pfizer, and Apotex
- Profiles and SWOT analyses of the major players in the medical device market: GlaxoSmithKline, AstraZeneca, Stryker, EssilorLuxottica, and DePuy Synthes
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Canadian healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Canada’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Canada’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership